Catalyst Wire Dossier Catalyst Wire Dossier

Azilsartan Medoxomil (Edarbi)

azilsartan medoxomil · Takeda Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Azilsartan Medoxomil (Edarbi), covering 2012-02-07 to 2012-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension [Phase 3]

See pricing